Therefore, further studies are needed to better understand the relationship between EGFR mutations and baseline brain metastasis, and clinicians should be aware of this relationship when they encounter cases of EGFR‐mutated NSCLC, or cases with brain metastasis. This evidence concerns the gene EGFR and non-small cell lung carcinoma.